Skip to content

Etizolam

NERVOUS SYSTEM

Also known as: AHR-3219, depas, Y 7131, Y-7131

YEAR INTRODUCED approvedATC N05BA19

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Etizolam is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1984. DrugCentral lists 4 molecular targets, including GABRA1|GABRG2|GABRB2, GABRG2|GABRB3|GABRA2 and GABRG2|GABRB3|GABRA3. Recorded indications include Anxiety.

  • Molecular targets: GABRA1|GABRG2|GABRB2, GABRG2|GABRB3|GABRA2, GABRG2|GABRB3|GABRA3 and GABRG2|GABRB3|GABRA5 (4 listed in DrugCentral).
  • Indications: Anxiety.
  • ATC code: N05BA19 (Benzodiazepine derivatives).
  • Molecular formula: C17H15ClN4S; molecular weight 342.85 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Anxiety

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
GABA-A receptor alpha-1/beta-2/gamma-2GABRA1|GABRG2|GABRB2unknownEC50 8.10
GABA-A receptor alpha-2/beta-3/gamma-2GABRG2|GABRB3|GABRA2unknown—
GABA-A receptor alpha-3/beta-3/gamma-2GABRG2|GABRB3|GABRA3unknown—
GABA-A receptor alpha-5/beta-3/gamma-2GABRG2|GABRB3|GABRA5unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1984-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
N05BA19NERVOUS SYSTEM › PSYCHOLEPTICS › ANXIOLYTICS › Benzodiazepine derivatives

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Toxicity to various agents1453.7
Drug abuse449.2
Respiratory depression243.3
Hepatic function abnormal195.8
Overdose192.7
Altered state of consciousness122.9
Pulmonary oedema121.7
Intentional overdose101.1
Alcohol interaction96.0
Interstitial lung disease93.8
Counterfeit product administered84.8
Fatigue83.1

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Etizolam is on its molecule page.

Molecular formulaC17H15ClN4S
Molecular weight342.85 g/mol
CAS number40054-69-1
InChIKeyVMZUTJCNQWMAGF-UHFFFAOYSA-N
PubChem CID3307
CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=C(Cl)C=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Etizolam used for?

DrugCentral lists the following indications for Etizolam: Anxiety.

How does Etizolam work?

Its molecular targets in DrugCentral include GABRA1|GABRG2|GABRB2, GABRG2|GABRB3|GABRA2, GABRG2|GABRB3|GABRA3 and GABRG2|GABRB3|GABRA5.

When was Etizolam first approved?

Etizolam was first approved by the YEAR INTRODUCED in 1984.

What is the chemical formula of Etizolam?

Etizolam has the molecular formula C17H15ClN4S and a molecular weight of 342.85 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1984-01-01
AgencyYEAR INTRODUCED
Targets4
Indications1
FormulaC17H15ClN4S
DrugCentral ID1102
Interactive profile